Literature DB >> 27038054

HDQLIFE: the development of two new computer adaptive tests for use in Huntington disease, Speech Difficulties, and Swallowing Difficulties.

N E Carlozzi1, S G Schilling2,3, J-S Lai4,5, J S Perlmutter6,7, M A Nance8,9, J F Waljee10, J A Miner2, S K Barton6, S M Goodnight2, P Dayalu11.   

Abstract

PURPOSE: Huntington disease (HD) is an autosomal dominant neurodegenerative disease which results in several progressive symptoms, including bulbar dysfunction (i.e., speech and swallowing difficulties). Although difficulties in speech and swallowing in HD have a negative impact on health-related quality of life, no patient-reported outcome measure exists to capture these difficulties that are specific to HD. Thus, we developed a new patient-reported outcome measure for use in the Huntington Disease Health-Related Quality of Life (HDQLIFE) Measurement System that focused on the impact that difficulties with speech and swallowing have on HRQOL in HD.
METHODS: Five hundred and seven individuals with prodromal and/or manifest HD completed 47 newly developed items examining speech and swallowing difficulties. Unidimensional item pools were identified using exploratory factor analysis and confirmatory factor analysis (EFA and CFA, respectively). Item response theory (IRT) was used to calibrate the final measures.
RESULTS: EFA and CFA identified two separate unidimensional sets of items: Speech Difficulties (27 items) and Swallowing Difficulties (16 items). Items were calibrated separately for these two measures and resulted in item banks that can be administered as computer adaptive tests (CATs) and/or 6-item, static short forms. Reliability of both of these measures was supported through high correlations between the simulated CAT scores and the full item bank.
CONCLUSIONS: CATs and 6-item calibrated short forms were developed for HDQLIFE Speech Difficulties and HDQLIFE Swallowing Difficulties. These measures both demonstrate excellent psychometric properties and may have clinical utility in other populations where speech and swallowing difficulties are prevalent.

Entities:  

Keywords:  HDQLIFE; Health-related quality of life; Huntington disease; Neuro-QoL; PROMIS; Patient-reported outcome (PRO); Speech difficulties; Swallowing difficulties

Mesh:

Year:  2016        PMID: 27038054      PMCID: PMC5011441          DOI: 10.1007/s11136-016-1273-y

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  26 in total

1.  Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

Authors:  J T Coyle; R Schwarcz
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

2.  Huntington disease: clinical care and evaluation.

Authors:  I Shoulson; S Fahn
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

3.  Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar.

Authors:  Paul K Crane; Laura E Gibbons; Lance Jolley; Gerald van Belle
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

4.  Huntington's disease mortality in the United States.

Authors:  D J Lanska; L Lavine; M J Lanska; B S Schoenberg
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

5.  Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing.

Authors:  Richard C Gershon; Jin Shei Lai; Rita Bode; Seung Choi; Claudia Moy; Tom Bleck; Deborah Miller; Amy Peterman; David Cella
Journal:  Qual Life Res       Date:  2011-08-27       Impact factor: 4.147

6.  The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity.

Authors:  Colleen A McHorney; Joanne Robbins; Kevin Lomax; John C Rosenbek; Kimberly Chignell; Amy E Kramer; D Earl Bricker
Journal:  Dysphagia       Date:  2002       Impact factor: 3.438

7.  Clinical validity of the SWAL-QOL and SWAL-CARE outcome tools with respect to bolus flow measures.

Authors:  Colleen A McHorney; Bonnie Martin-Harris; JoAnne Robbins; John Rosenbek
Journal:  Dysphagia       Date:  2006-07       Impact factor: 3.438

8.  Having a fit: impact of number of items and distribution of data on traditional criteria for assessing IRT's unidimensionality assumption.

Authors:  Karon F Cook; Michael A Kallen; Dagmar Amtmann
Journal:  Qual Life Res       Date:  2009-03-18       Impact factor: 4.147

9.  Huntington's disease: a randomized, controlled trial using the NMDA-antagonist amantadine.

Authors:  L Verhagen Metman; M J Morris; C Farmer; M Gillespie; K Mosby; J Wuu; T N Chase
Journal:  Neurology       Date:  2002-09-10       Impact factor: 9.910

10.  Causes of death in patients with Huntington's disease and in unaffected first degree relatives.

Authors:  S A Sørensen; K Fenger
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

View more
  19 in total

Review 1.  Management of dysphagia in Huntington's disease: a descriptive review.

Authors:  Nicole Pizzorni; Francesca Pirola; Andrea Ciammola; Antonio Schindler
Journal:  Neurol Sci       Date:  2020-01-27       Impact factor: 3.307

2.  Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes.

Authors:  Rebecca E Ready; Nicholas R Boileau; Stacey K Barton; Jin-Shei Lai; Michael K McCormack; David Cella; Nora E Fritz; Jane S Paulsen; Noelle E Carlozzi
Journal:  J Huntingtons Dis       Date:  2019

3.  A new measure for end of life planning, preparation, and preferences in Huntington disease: HDQLIFE end of life planning.

Authors:  Noelle E Carlozzi; E A Hahn; S A Frank; J S Perlmutter; N D Downing; M K McCormack; S Barton; M A Nance; S G Schilling
Journal:  J Neurol       Date:  2017-11-15       Impact factor: 4.849

4.  Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.

Authors:  Carey Wexler Sherman; Ravi Iyer; Victor Abler; Alexandria Antonelli; Noelle E Carlozzi
Journal:  Neuropsychol Rehabil       Date:  2019-03-08       Impact factor: 2.868

Review 5.  The Spectrum of Functional Rating Scales in Neurology Clinical Trials.

Authors:  Pushpa Narayanaswami
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

6.  HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.

Authors:  Noelle E Carlozzi; Nicholas R Boileau; Kelvin L Chou; Rebecca E Ready; David Cella; Michael K McCormack; Jennifer A Miner; Praveen Dayalu
Journal:  Mov Disord       Date:  2019-11-14       Impact factor: 10.338

7.  Understanding the need for assistance with survey completion in people with Huntington disease.

Authors:  Elizabeth A Hahn; Nancy R Downing; Julie C Stout; Jane S Paulsen; Becky Ready; Siera Goodnight; Jin-Shei Lai; Jennifer A Miner; Noelle E Carlozzi
Journal:  Qual Life Res       Date:  2017-12-06       Impact factor: 4.147

8.  Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Authors:  Nora E Fritz; Nicholas R Boileau; Julie C Stout; Rebecca Ready; Joel S Perlmutter; Jane S Paulsen; Kimberly Quaid; Stacey Barton; Michael K McCormack; Susan L Perlman; Noelle E Carlozzi
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2018-03-21       Impact factor: 2.198

9.  HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).

Authors:  N E Carlozzi; S G Schilling; J-S Lai; J S Paulsen; E A Hahn; J S Perlmutter; C A Ross; N R Downing; A L Kratz; M K McCormack; M A Nance; K A Quaid; J C Stout; R C Gershon; R E Ready; J A Miner; S K Barton; S L Perlman; S M Rao; S Frank; I Shoulson; H Marin; M D Geschwind; P Dayalu; S M Goodnight; D Cella
Journal:  Qual Life Res       Date:  2016-08-13       Impact factor: 4.147

10.  Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Authors:  N E Carlozzi; S Schilling; A L Kratz; J S Paulsen; S Frank; J C Stout
Journal:  Qual Life Res       Date:  2018-06-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.